duelittle2
20 hours ago
Grok, what is the source of your information when you say 'it was noted that Prodigy Health Plus (formerly Liberty Health Plus) had already captured a multi-million-dollar market share.' Also, if applicable, who was the information noted by?"
The information regarding Prodigy Health Plus (formerly Liberty Health Plus) capturing a multi-million-dollar market share comes from announcements made by Cann American Corp. following their acquisition of Liberty Health Plus, which was subsequently rebranded as Prodigy Health Plus. This was reported in various business and financial news outlets in May 2023, including Yahoo Finance, Street Insider, Toronto Telegraph, and Accesswire. These reports detailed the acquisition and the existing market share of Liberty Health Plus at the time, which was facilitated through services administered by Careington International Corporation. The specific details about the market share were part of Cann American Corp.'s press releases and updates, but the reports did not attribute the noting of this information to a specific individual beyond the company's announcements.
details on acquisition
Cann American Corp. announced its acquisition of Liberty Health Plus, which was later rebranded as Prodigy Health Plus, in May 2023. The acquisition was completed on May 10, 2023, and was part of Cann American Corp.'s strategy to expand into the telehealth and discount drug markets, leveraging Liberty Health Plus's existing services and market presence.
Key details of the acquisition include:
Date of Completion: The acquisition was finalized on May 10, 2023, with announcements made on May 24, 2023, across various platforms.
Rebranding: Liberty Health Plus was rebranded as Prodigy Health Plus to align with Cann American Corp.'s branding strategy and to support synergy across its portfolio, which includes other Prodigy-named subsidiaries like Prodigy Stem Cell.
Services and Market Share: At the time of acquisition, Liberty Health Plus had already captured a multi-million-dollar market share in the telehealth and discount drug markets. Its services, administered through partnerships with Careington International Corporation, included telehealth, pet care, prescription drugs, vision, and dental plans. Prodigy Health Plus RX, a notable offering, was highlighted as the nation's first free pharmacy, providing access to 605 commonly prescribed generic medications at no cost through a membership-based plan, available at 64,000 pharmacies nationwide.
Leadership Changes: Michael Kramer, the founder of Liberty Health Plus, was appointed to the board of directors of Cann American Corp. following the acquisition, bringing his expertise to the company's strategic direction.
Strategic Goals: The acquisition was part of Cann American Corp.'s broader strategy to build a diverse portfolio of revenue-generating subsidiaries under the Prodigy name. It aimed to integrate Prodigy Health Plus's services with other offerings, such as regenerative medicine treatments from Prodigy Stem Cell, and to expand access to affordable healthcare solutions nationwide.
Financial and Operational Context: The acquisition was non-dilutive, meaning it did not involve issuing new shares that could dilute existing shareholders' value. Cann American Corp. also engaged Dr. Jason Schottel as a consultant to guide Prodigy Health Plus patients toward regenerative therapies and to advise on launching wellness centers and speaking at Prodigy-sponsored seminars. The company projected increased revenue, estimating $10 million for 2023, partly due to the rapid expansion opportunities in markets like Florida, facilitated by Dr. Schottel's established presence.
Audit and Compliance: Concurrently, Cann American Corp. was undergoing an audit process, with all necessary documentation and financial information provided to the auditor by May 24, 2023. The company expected to resolve the audit and achieve OTCQB status, aiming to increase shareholder value.
This acquisition was reported in financial and business news outlets such as Yahoo Finance, Street Insider, Toronto Telegraph, and Accesswire, reflecting Cann American Corp.'s focus on expanding its footprint in the alternative therapeutics sector, particularly in telehealth and discount healthcare services.
telehealth market trends
The telehealth market has experienced significant growth in recent years, driven by technological advancements, regulatory changes, and increasing demand for accessible healthcare. Below are key trends shaping the telehealth market as of 2025:
Market Growth and Valuation
The global telehealth market was valued at USD 101.15 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 24.3% from 2024 to 2030, reaching USD 455.27 billion by 2030. Alternative estimates suggest the market could reach USD 180.86 billion by 2030, with a CAGR of 11.5% from 2024 to 2030, reflecting varied growth projections based on different methodologies.
North America, particularly the U.S., dominates the market, with the U.S. telehealth market valued at USD 42.54 billion in 2024 and expected to grow at a CAGR of 23.8% from 2025 to 2030. This dominance is driven by high internet penetration, smartphone adoption, and favorable government initiatives.
Key Drivers
Technological Advancements: The integration of artificial intelligence (AI) and machine learning in telehealth platforms enhances diagnostics, predictive analytics, and personalized treatment plans. AI-powered tools, such as chatbots and virtual health assistants, provide round-the-clock patient support.
Aging Population and Chronic Diseases: An aging global population and rising prevalence of chronic conditions like diabetes and cardiovascular diseases increase the demand for remote monitoring and telehealth solutions. Remote patient monitoring (RPM) systems, including wearables and sensors, are increasingly adopted for managing chronic care.
Regulatory Support and Reimbursement Policies: Governments worldwide are expanding telehealth regulations and reimbursement frameworks. For instance, in the U.S., Medicare telehealth flexibilities extended through March 2025 are supporting continued investment in virtual care, though uncertainties remain under changing administrations.
COVID-19 Legacy: The pandemic accelerated telehealth adoption, with virtual consultations and remote monitoring becoming mainstream. This trend continues as patients and providers recognize the convenience and cost-effectiveness of telehealth.
Digital Health Literacy and Accessibility: Efforts to improve digital health literacy and user-friendly telehealth solutions are crucial as more patients rely on remote care. Enhanced internet connectivity and smartphone penetration (expected to reach 84% globally by 2025) further support accessibility.
Emerging Trends
AI and Predictive Analytics: AI is transforming telehealth by offering faster diagnostics and tailored treatment plans. AI-enabled tools, such as Vitalchat's E-Sitter for inpatient telehealth, are enhancing patient-provider interactions.
Telepharmacy Growth: Telepharmacy is becoming a pivotal component, offering services like digital prescription transfers and remote treatment adherence. This trend is vital for chronic care management and is supported by regulatory changes.
Hybrid Care Models: Blending virtual and in-person consultations optimizes efficiency and strengthens patient-provider relationships. This model is gaining traction as providers aim to balance convenience with clinical needs.
Mental Health Services: Telepsychiatry is expanding, with more countries, particularly in Europe, enhancing mental health offerings via telemedicine. Posts found on X indicate significant growth in mental health telehealth, with organizations increasingly including these options in benefits packages.
Remote Patient Monitoring (RPM): RPM is a blockbuster trend, especially in the U.S., where nearly 20% of large healthcare facilities have adopted RPM for managing chronic disorders, post-surgical recovery, and elderly care. Approximately 90% of patients report experiencing some form of remote healthcare in the past year.
International Collaboration: Regulatory frameworks are adapting to support cross-border virtual care, enhancing global healthcare accessibility. This trend is expected to grow, connecting patients with specialized expertise regardless of location.
Cybersecurity Concerns: As telehealth relies on connected devices, healthcare organizations face increasing cyberattacks. Strengthening cyber defenses is a priority, with experts noting the need for robust security measures to protect patient data.
Challenges and Uncertainties
Regulatory Uncertainty: In the U.S., the expiration of Medicare telehealth flexibilities in March 2025 adds anxiety for providers, potentially hampering investment in virtual care. The shape of AI and telehealth regulation under the Trump administration remains unclear.
Equity and Access: While telehealth bridges gaps, disparities persist, particularly in underserved and rural areas. Efforts to enhance digital literacy and internet access are critical to addressing these disparities.
Data Security and Privacy: Concerns about data security remain, with patients and providers emphasizing the need for secure platforms. Regulatory compliance, such as HIPAA in the U.S., is driving demand for advanced telehealth software.
Market Sentiment and Investment
Posts found on X highlight strong investor confidence in telehealth, with companies like Hims & Hers noted for their growth potential. The total addressable market for telehealth was estimated at USD 161 billion in 2024, with significant room for expansion.
Digital health funding is expected to increase in 2025, with some companies considering initial public offerings (IPOs). Experts suggest that successful IPOs could encourage further market entries, driven by a maturing revenue scale compared to earlier digital health IPOs.
Future Outlook
The telehealth market is poised for continued growth, with innovations in AI, RPM, and telepharmacy leading the way. The integration of telehealth into mainstream medical practices will further reduce healthcare disparities and enhance efficiency.
As policies evolve and technology advances, the global telehealth market will expand, offering new opportunities to revolutionize patient care. The focus will remain on improving accessibility, enhancing patient outcomes, and ensuring cost-effectiveness.
These trends reflect the dynamic evolution of the telehealth market, positioning it as a cornerstone of modern healthcare delivery in 2025 and beyond.
telehealth regulatory changes
Telehealth regulatory changes have been significant in recent years, driven by the COVID-19 pandemic, evolving healthcare needs, and ongoing legislative efforts. Below is an overview of key regulatory changes and updates as of 2025, focusing on federal and state-level developments:
Federal Regulatory Changes
Medicare Telehealth Flexibilities:
The American Relief Act, signed on December 21, 2024, extended certain telehealth flexibilities for Medicare services through March 31, 2025. These include:
Waiver of geographic restrictions, allowing patients in urban, suburban, and rural areas to access telehealth services.
Removal of originating site restrictions, enabling Medicare beneficiaries to receive telehealth services from their homes or any site with telecommunications access.
Continued eligibility for Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) to serve as distant site providers for non-behavioral/mental telehealth services.
Waiver of in-person visit requirements for behavioral/mental health telehealth services within six months of the initial visit and annually thereafter (through March 31, 2025).
Allowance of audio-only telehealth for non-behavioral/mental health services through March 31, 2025.
Without further congressional action, these flexibilities will expire on March 31, 2025, reinstating pre-pandemic restrictions, such as geographic limitations and site-specific requirements. Posts found on X highlight concerns about the potential loss of telehealth access for rural and underserved communities if these waivers lapse.
The Calendar Year (CY) 2025 Medicare Physician Fee Schedule (PFS) Final Rule, effective January 1, 2025, introduced permanent and temporary changes within CMS's regulatory authority:
Permanent Changes:
Revised the definition of "interactive telecommunications system" to include two-way, real-time audio-only communication for telehealth services provided to patients in their homes, but only if the patient is unable or unwilling to use video technology, and the provider is technically capable of video. This applies to all telehealth services, including mental health.
Added certain behavioral and mental health services to the permanent Medicare telehealth list.
Temporary Extensions (through December 31, 2025):
Extended "remote direct supervision," allowing supervising practitioners to be immediately available via real-time audio and visual interactive telecommunications for certain services, including incident-to services and diagnostic tests.
Continued flexibility for telehealth practitioners to bill from their enrolled practice location instead of their home address when providing services from home, addressing privacy and safety concerns.
Allowed teaching physicians to have a virtual presence in all teaching settings for Medicare telehealth services.
Controlled Substances Prescribing via Telehealth:
On November 15, 2024, the Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) extended flexibilities for prescribing controlled substances (Schedules II-V) via telehealth without an in-person evaluation until December 31, 2025. This extension aims to balance access and safety, with ongoing discussions about permanent rules. Posts found on X indicate that healthcare groups are reviewing these changes and providing feedback.
CPT Code Updates:
Effective January 1, 2025, audio-only telemedicine CPT codes 99441–99443 were deleted to reduce redundancy. However, CMS did not recognize 16 of the 17 new telehealth CPT codes (98000–98015) introduced for 2025, assigning them an "Invalid" status for Medicare reimbursement. Providers must use standard Evaluation and Management (E/M) codes (e.g., 99202–99215) with appropriate modifiers (e.g., 95 for audio-visual, 93 for audio-only) for most telehealth services.
CMS will pay separately for brief virtual check-in encounters (CPT code 98016) in lieu of HCPCS code G2012, which was deleted due to redundancy.
Place of Service (POS) Codes:
CMS continues to use two POS codes for telehealth: POS 02 (patient not in their home) and POS 10 (patient in their home), with POS 10 paid at the non-facility rate. These designations remain unchanged for 2025.
Legislative Uncertainty:
The expiration of Medicare telehealth waivers on March 31, 2025, poses challenges for providers and patients. Legislation like the Telehealth Modernization Act of 2024, which sought to permanently extend flexibilities, was still in committee as of September 2024. Posts found on X express concerns about the impact on Medicare patients, with more than 85% of telehealth encounters potentially invalid for payment if waivers lapse.
Congressional action is needed to extend or make permanent these flexibilities. The AMA and other organizations advocate for swift passage of bills like the Preserving Telehealth, Hospital, and Ambulance Access Act (H.R. 8261) to ensure continuity of care.
State-Level Regulatory Changes
Payment Parity:
As of January 2025, 22 states have implemented permanent payment parity for telehealth services, requiring insurers (commercial, Medicaid, or others) to reimburse providers at the same rate as in-person care. Seven states have payment parity with caveats, and 21 states have no parity requirement. These policies vary by state and are updated quarterly.
Posts found on X indicate ongoing debates about state-level telehealth coverage, with some states considering cuts to telehealth programs due to budget constraints, particularly affecting rural and underserved areas.
Licensure and Cross-State Practice:
Telehealth licensure requirements remain state-specific, with providers generally required to be licensed in the state where the patient is located. The Interstate Medical Licensure Compact (IMLC) facilitates cross-state licensing for participating states, but challenges persist for patients seeking care from out-of-state specialists.
Temporary licenses issued during the pandemic have largely expired, though some states continue to explore cross-state licensing reforms to enhance access.
Medicaid Telehealth Policies:
State Medicaid programs vary in telehealth coverage. For dual-eligible patients (Medicare and Medicaid), providers must check state-specific Medicaid policies for telehealth reimbursement. Posts found on X highlight efforts by some states, like Pennsylvania, to eliminate restrictions on behavioral health outpatient telehealth services, enhancing access.
Privacy and Security:
States continue to align telehealth privacy regulations with federal standards like HIPAA. However, the increased use of telehealth has raised concerns about data security, prompting states to strengthen cybersecurity measures.
Emerging Regulatory Considerations
AI and Digital Health Integration:
Regulatory frameworks are evolving to address the integration of AI in telehealth, particularly for clinical decision support and patient monitoring. States and federal agencies are focusing on responsible AI use, with ongoing discussions about compliance and liability.
Posts found on X note the FDA's growing approval of digital therapeutics, which may influence telehealth regulations.
Health Equity and Access:
Regulatory changes aim to address disparities in telehealth access, particularly for rural and underserved populations. However, posts found on X express concerns about potential cuts to telehealth coverage under new budget plans, which could disproportionately affect these communities.
Efforts to improve digital health literacy and broadband access are critical to ensuring equitable telehealth implementation.
Compliance and Enforcement:
Posts found on X highlight compliance changes, such as the end of telehealth relief for High Deductible Health Plans (HDHPs) affecting HSA eligibility, and the need for providers to stay updated on state-specific policies.
Federal audits and enforcement actions are increasing to address potential fraud in telehealth, with the HHS issuing new audits to ensure compliance.
Future Outlook
The telehealth regulatory landscape remains dynamic, with ongoing debates about permanent versus temporary flexibilities. Congressional action is crucial to extend Medicare waivers beyond March 31, 2025, and to address gaps in access and reimbursement.
State-level policies will continue to evolve, with a focus on payment parity, licensure, and equity. Providers must prepare for potential changes, including drafting patient communications and contingency plans for billing and service delivery.
The integration of AI and digital health tools will drive further regulatory updates, emphasizing the need for robust cybersecurity and compliance frameworks.
These regulatory changes reflect the ongoing effort to balance access, quality, and sustainability in telehealth, with significant implications for providers, patients, and policymakers in 2025 and beyond.
xxxxxxx
Hi_Lo
4 days ago
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/
Besides his hijacking antics, Miller has also faced some legal pressure in a separate civil suit filed against him in the United States District Court for the Northern District of Illinois by David Goulding, Howard Salamon, Robyn Goulding, and John O’Shea, regarding a company named Capitol Capital Corporation. According to the court documents, the individuals collaborated, together with Jason Black, to create a convertible debt Note in Indo Global Exchanges Pte Ltd (IGEX) in the name of Capitol Capital Corporation, using old existing debt and alleged “service fees”. The individuals then agreed to split the proceeds from the stock sales.
Court documents show that Capitol Capital Corporation received several big chunks of stock in IGEX, then transferred the shares to Tiger Trout Capital LLC, a Puerto Rican entity controlled by Alan Masley. A bank statement from December 2019 provided in the lawsuit shows that Tiger Trout Capital LLC would then transfer money back to Capitol Capital Corporation, who, in turn, split the money between Mark Miller and Jason Black (Market Cap Concepts LLC). At the time, Jason Black was the CEO of IGEX, and none of the debt conversions were disclosed in any of the IGEX OTC filings.
Public records show that Capitol Capital Corporation has also been involved as a noteholder in at least three other public issuers that used Jason Black as the CEO, MedX Holdings Inc (MEDH), Cann American Corp (CNNA), and Seven Arts Entertainment, Inc (SAPX).
CNNA recently appointed Jason Tucker, former CEO of LEAS, as its new CEO, giving it yet another connection to past Miller frauds. And according to SAPX OTC disclosures, on December 27, 2022, all the debt notes previously put in the name of Capitol Capital Corporation were transferred to an entity named Via Capital, represented in the SAPX filings by Jesus Cipriano, keeping the notes active despite Mark Miller’s various legal issues. Via Capital immediately started converting the debt into large chunks of free trading stock, including 150,000,000 shares on December 28, 2022, 150,000,000 shares on February 21, 2023, and 180,000,000 shares on March 6, 2023. SAPX has also begun to issue new debt notes to Via Capital.
Previously, in December 2020, Gary Kouletas (PAG Group LLC), who was another insider in LEAS and MEDH, was arrested and charged in a separate pump & dump scheme involving Global Resource Energy Inc (GBEN). That Indictment references an unnamed “Cooperating Witness” who is described as “a stock promoter and CEO of several public companies under federal investigation for securities fraud-related offenses but not yet charged.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170221017
Share selling scam exposed (IGEX, MEDH, SAPX, CNNA)
Hi_Lo
4 days ago
Straight from the SEC website:
https://www.sec.gov/enforcement-litigation/litigation-releases/lr-25469
Rahim Mohamed, Davies (Dave") Wong
SEC Charges 18 Defendants in International Scheme to Manipulate Stocks Using Hacked US Brokerage Accounts
Litigation Release No. 25469 / August 16, 2022
Securities and Exchange Commission v. Rahim Mohamed, Davies ("Dave") Wong, Glenn B. Laken, Richard C.S. Tang, Zoltan Nagy, Jeffrey D. Cox, Phillip G. Sewell, Breanne M. Wong, Christophe Merani, Anna Tang, Robert W. Seeley, Richard B. Smith, Christopher R. Smith, H.E. Capital SA, POP Holdings Ltd., Maximum Ventures Holdings LLC, Harmony Ridge Corp., and Avatele Group LLC, Defendants, and 9224-3708 Quebec, Inc., a/k/a Distributions Bano, and Jason Black, Relief Defendants, No. 1:22-cv-03252 (N.D. Ga. filed Aug. 15, 2022)
The Securities and Exchange Commission today charged 18 individuals and entities for their roles in a fraudulent scheme in which dozens of online retail brokerage accounts were hacked and improperly used to purchase microcap stocks to manipulate the price and trading volume of those stocks. Those charged include Rahim Mohamed of Alberta, Canada, who is alleged to have coordinated the hacking attacks, and several others in and outside the U.S. who allegedly benefited from or participated in the scheme.
According to the SEC's complaint, in late 2017 and early 2018, hackers accessed at least 31 U.S. retail brokerage accounts and used them to purchase the securities of Lotus Bio-Technology Development Corp. and Good Gaming, Inc. The unauthorized purchases allegedly enabled fraudsters, who already controlled large blocks of Lotus Bio-Tech and Good Gaming stock, to sell their holdings at artificially high prices and reap more than $1 million in illicit proceeds. According to the complaint, Davies Wong of British Columbia, Canada, and Glenn B. Laken of Illinois, respectively, controlled the majority of the Lotus Bio-Tech and Good Gaming stock that was sold while the hacking attacks were being carried out, and Mohamed coordinated with Davies Wong, Laken, and others to orchestrate the attacks. The complaint also alleges that Richard Tang of British Columbia, Canada, was involved with both the Lotus Bio-Tech and Good Gaming schemes.
The SEC's complaint charges violations of the antifraud and beneficial ownership reporting provisions of the Securities Act of 1933 ("Securities Act") and the Securities Exchange Act of 1934 ("Exchange Act"), and names two relief defendants who received proceeds from the hacks. More specifically, the complaint charges the following defendants with the following violations:
• Rahim Mohamed of Alberta, Canada, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Sections 9(a) and 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
• Davies Wong of British Columbia, Canada, Richard Tang of British Columbia, Canada, Zoltan Nagy of British Columbia, Canada, Anna Tang of British Columbia, Canada, and Breanne Wong of British Columbia, Canada and Panama, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder, and directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder;
• Glenn B. Laken of Illinois, Jeffrey Cox of Alberta, Canada, Christophe Merani of Illinois, and Phillip Sewell of British Columbia, Canada, with directly violating, and aiding and abetting violations of, Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
• Robert Seeley of the Dominican Republic, Christopher R. Smith of the Dominican Republic, Richard B. Smith of the Dominican Republic, Wyoming entity Harmony Ridge Corp., and Nevis entities H.E. Capital SA and POP Holdings Ltd., with aiding and abetting violations of Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder;
• Wyoming entity Maximum Ventures Holdings LLC, with aiding and abetting violations of Section 17(a) of the Securities Act, and Section 10(b) of the Exchange Act, and Rule 10b-5 thereunder, and directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder; and
• Wyoming entity Avatele Group LLC, with directly violating Sections 13(d) and 16(a) of the Exchange Act, and Rules 13d-1 and 16a-3 thereunder.
The SEC's complaint also names Quebec, Canada entity 9224-3708 Quebec Inc., a/k/a Distributions Bano, and Jason Black of California and/or Georgia, as relief defendants. The SEC seeks the return of ill-gotten gains plus interest, penalties, bars, and other equitable relief. The SEC's investigation is continuing.
The SEC's investigation has been conducted by Joshua Dickman and Lucy Graetz of the Atlanta Regional Office, Andrew McFall of the Washington, D.C. Office, and Patrick McCluskey of the Philadelphia Regional Office, with the assistance of Marlee Miller and Owen Granke of the SEC's Office of International Affairs. The case is being supervised by Acting Chief of the Crypto Assets and Cyber Unit Carolyn Welshhans, Market Abuse Unit Chief Joseph Sansone, Justin Jeffries and Natalie Brunson of the Atlanta Regional Office, and Amy Flaherty Hartman of the Chicago Regional Office. Robert Gordon and William Hicks of the Atlanta Regional Office will lead the SEC's litigation, supervised by M. Graham Loomis.
The SEC appreciates the assistance of the Financial Industry Regulatory Authority, the Alberta Securities Commission, the Australia Securities and Investments Commission, the British Columbia Securities Commission, the Calgary Police Service, the Cayman Islands Monetary Authority, the Dubai Financial Services Authority, the French Autoritƒ© des Marchƒ©s Financiers, the Hong Kong Securities and Futures Commission, the Mauritius Financial Services Commission, the Ontario Securities Commission, the Quebec Autoritƒ© des Marchƒ©s Financiers, the Royal Canadian Mounted Police, the Securities Commission of the Bahamas, the Sƒ»retƒ© du Quƒ©bec, the Superintendencia del Mercado de Valores de la Repƒºblica Dominicana, the Swiss Financial Market Supervisory Authority, and the United Kingdom Financial Conduct Authority.
To learn more about how to protect your online investment accounts from fraud, please visit the SEC's Office of Investor Education and Advocacy investor alerts webpage.
• SEC Complaint
Last Reviewed or Updated: May 31, 2023
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
ysung
2 hours ago
Lime Time
6 hours ago
Squirrely_McShitty
21 hours ago
drugmanrx
3 days ago
Homebrew
3 days ago
Ecomike
4 days ago
Hot Features
Premium
